Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.

MLA

Rabbani, Leroy E., et al. “Impact of Thienopyridine Administration Prior to Primary Stenting in Acute Myocardial Infarction.” Journal of Interventional Cardiology, vol. 22, no. 4, Aug. 2009, pp. 378–84. EBSCOhost, https://doi.org/10.1111/j.1540-8183.2009.00474.x.

APA

Rabbani, L. E., Iyengar, S., Dangas, G. D., Grines, C. L., Cox, D. A., Garcia, E., Tcheng, J. E., Griffin, J. J., Guagliumi, G., Stuckey, T., Turco, M., Stant, J., Fahy, M., Lansky, A. J., Mehran, R., & Stone, G. W. (2009). Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. Journal of Interventional Cardiology, 22(4), 378–384. https://doi.org/10.1111/j.1540-8183.2009.00474.x

Chicago

Rabbani, Leroy E, Srinivas Iyengar, George D Dangas, Cindy L Grines, David A Cox, Eulogio Garcia, James E Tcheng, et al. 2009. “Impact of Thienopyridine Administration Prior to Primary Stenting in Acute Myocardial Infarction.” Journal of Interventional Cardiology 22 (4): 378–84. doi:10.1111/j.1540-8183.2009.00474.x.